CVE.TOCVE.TOTSX
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -10.57% | +1.81% | -15.52% | -7.40% | -7.35% |
| Gross Profit Growth | -7.33% | -24.11% | -51.51% | +165.74% | +33.67% |
| EBITDA Growth | -32.96% | -9.97% | -13.78% | +14.54% | +61.23% |
| Operating Income Growth | -20.95% | -24.74% | -56.23% | +189.88% | +37.07% |
| Net Income Growth | -80.35% | -26.96% | -14.90% | +56.83% | +539.73% |
| EPS Growth | -80.77% | -24.19% | -11.32% | +71.43% | +580.00% |
| EPS Diluted Growth | -81.97% | -24.19% | -11.32% | +71.43% | +611.24% |
| Weighted Average Shares Growth | -3.14% | -2.49% | -2.62% | -3.05% | +0.24% |
| Weighted Average Shares Diluted Growth | +3.99% | -2.50% | -2.71% | -3.79% | -4.76% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -31.13% | -31.69% | -15.43% | -13.86% | +18.68% |
| Free Cash Flow Growth | -68.98% | -90.33% | -26.76% | -14.15% | +105.99% |
| Receivables Growth | -17.17% | -24.56% | -23.46% | -13.34% | +29.72% |
| Inventory Growth | +11.56% | -2.71% | -14.94% | -23.68% | -25.51% |
| Asset Growth | +4.87% | +2.52% | -0.32% | -2.02% | +12.18% |
| Book Value per Share Growth | +7.04% | +3.59% | +0.60% | -1.10% | +6.02% |
| Debt Growth | +6.93% | +9.63% | +4.73% | +0.89% | +59.99% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +183.10% | -19.92% | -12.57% | +28.49% | +20.40% |